Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Licenses Molecular Dx Technology from DxS and BTG

NEW YORK, June 28 (GenomeWeb News) - Bayer HealthCare's diagnostics has licensed Amplification Refractory Mutation System DNA diagnostic technology from DxS and BTG, the companies said today.


Bayer said that it licensed the ARMS technology to develop diagnostic assays, including pharmacogenomic assays.


Financial terms of the deal were not disclosed.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.